Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Estimating stack distances
Oxide material, electrophotographic photoreceptor, process cartridge, and image forming device
Kit and method for the capture of tumor cells
Vehicle window opening and closing control device
Signal apparatus for facilitating safe backup of vehicles
Techniques for determining optimized local repair paths
  Randomly Featured Patents
Low temperature reflow method for filling high aspect ratio contacts
Semiconductor layered structure and its method of formation, and light emitting device
Control for selecting automated transmission system shift strategy
System for changing priority of information
Copy server for collaboration and electronic commerce
Mobile phone power-saving by usage learning
Interlock system for a gasoline dispensing nozzle
Flame scanner collimator body
Vacuum operated sealed liquid accumulator
Flame and smoke spread retardant molding compounds and components molded from these compounds